Years of research laid groundwork for speedy COVID-19 shots How could scientists race out COVID-19 vaccines so fast without cutting corners? A head start helped -- over a decade of behind-the-scenes research that had new vaccine technology poised for a... AP NEWS

How could scientists race out COVID-19 vaccines so fast without cutting corners? A head start helped -- over a decade of behind-the-scenes research that had new vaccine technology poised for a challenge just as the coronavirus erupted.

NEW YORK (Reuters) - Clarence Hamer doesn’t expect to hang on to his house much longer.

His downstairs tenant owes him nearly $50,000 in back rent on the four-bedroom duplex he owns in Brownsville, Brooklyn. Without those rental payments, Hamer has been unable to pay the thousands he owes in heat, hot water and property taxes. In September, after exhausting his life savings, he stopped paying the mortgage, too.

“I don’t have any corporate backing or any other type of insurance,” said Hamer, a 46-year-old landlord who works for the city of New York. “All I have is my home, and it seems apparent that I’m going to lose it.”

America’s mom-and-pop landlords, along with their tenants, have been dangling by a thread for nine months. Now, with Congress still deadlocked over the contours of a second pandemic stimulus package, they are entering a new housing abyss, a perilous period of pandemic limbo as the last of the safety nets are set to expire.

In early September, officials in South Korea announced an ambitious plan to vaccinate 30 million people against the flu — 10 million more than last year, an increase aimed at keeping down rates of the flu while the country battled the coronavirus.

But as The Times reported last week, the internet soon got in the way. As the vaccine was distributed, a few logistical problems popped up, and South Koreans began circulating grave stories online — pictures of vaccine boxes that looked like they had been stored unsafely, reports of vaccine contaminated with mysterious white particles.

https://www.nytimes.com/live/2020/12/07/world/covid-19-coronavirus#trump-covid-vaccine-pfizer

Trump administration officials passed when Pfizer offered in late summer to sell the U.S. government additional doses of its Covid-19 vaccine, according to people familiar with the matter. Now Pfizer may not be able provide more of its vaccine to the United States until next June because of its commitments to other countries, they said.

As the administration scrambles to try to purchase more doses of the vaccine, President Trump plans on Tuesday to sign an executive order “to ensure that United States government prioritizes getting the vaccine to American citizens before sending it to other nations,” according to a draft statement and a White House official, though it was not immediately clear what force the president’s executive order would carry.

That included whether it would expand the U.S. supply of doses beyond what is spelled out in existing federal contracts.